• Please Remember: Members are only permitted to share their own experiences. Members are not qualified to give medical advice. Additionally, everyone manages their health differently. Please be respectful of other people's opinions about their own diabetes management.
  • We seem to be having technical difficulties with new user accounts. If you are trying to register please check your Spam or Junk folder for your confirmation email. If you still haven't received a confirmation email, please reach out to our support inbox: support.forum@diabetes.org.uk

Review of 2025 diabetes conference.

Amity Island

Amity Island

Well-Known Member
Relationship to Diabetes
Type 1
The Diabetes UK Professional Conference 2025: How the NHS three shifts are shaping the future of diabetes care.

This blog shares our reflections, viewed through the lens of the NHS’s three shifts: moving care from hospitals to communities, making better use of technology, and focusing on preventing sickness rather than just treating it.

healthinnovationnetwork.com

The Diabetes UK Professional Conference 2025: How the NHS three shifts are shaping the future of diabetes care - Health Innovation Network

The Health Innovation Network is the Academic Health Science Network (AHSN) for south London, one of 15 AHSNs across England.
healthinnovationnetwork.com healthinnovationnetwork.com
 
To forum members.

I am a regular contributor to the news thread on this forum, to try and keep the forum fresh and worthy of return views. Although I have no issues with the occasional thank you or like for my time and effort or even a good civilised debate, but please don't come on here to abuse, slander and insult. As hard as I try, I don't always get things right, understand everything or present everything accurately, but it is certainly NOT my intention to deliberately mislead, lie, misinform or upset people.
 
Last edited:
In summary NHS’s three shifts:

1. Moving care from hospitals to communities.
NHS’s ambition to reduce reliance on hospital services and strengthen community-based care. The importance of peer support, the benefits of which is not as easy to articulate as say medical treatments, where the outcomes are more simple to evidence.

2. Making better use of technology.
Despite the success of cgm and closed loop for type 1's, for use in type 2's challenges around the evidence base, scalability, and cost were cited.

3. Focusing on preventing sickness rather than just treating it.
Early onset type 2 diabetes received considerable attention, with speakers sharing the importance of multidisciplinary teams delivering rapid, holistic interventions aimed at remission.

Screening and early intervention for type 1 diabetes were also discussed in depth. The ELSA and T1DRA studies demonstrated the feasibility and benefits of early identification through antibody testing.

The rise of weight management medications like Mounjaro (tirzepatide) remains a hot topic. With significant outcomes, including up to 86% of individuals achieving at least 10% body weight loss.
 
You must log in or register to reply here.
Back
Top